Virescent Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
All Gallg.cominDec 2025 · $10M
All G produces precision-fermented proteins including bovine and human lactoferrin (such as its apo-lactoferrin LFX product), micellar caseins, and human milk proteins for use in functional foods, dietary supplements, infant formula, personal care, and therapeutics.
BiotechDeep TechFoodTech
Co-investorsAgronomicsEllerston CapitalXeraya Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.